veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
remesolin 20 mg gastro - resistant capsules, hard
actavis group ptc ehf. - 20 mg gastro - resistant capsules, hard
remesolin 40 mg gastro - resistant capsules, hard
actavis group ptc ehf. - 40 mg gastro - resistant capsules, hard
remesolin 20 mg gastro - resistant tablets
actavis group ptc ehf. - 20 mg gastro - resistant tablets
remesolin 40 mg gastro - resistant tablets
actavis group ptc ehf. - 40 mg gastro - resistant tablets